109 related articles for article (PubMed ID: 10983377)
1. [Expression of VEGF, KDR, p53, E6 HPV16 and HPV18 in vulvar and cervix cancer].
Michalski B; Mazurek U; Olejek A; Kuśmierz D; Poreba R; Witek A; Wilczok T
Wiad Lek; 2000; 53(5-6):240-6. PubMed ID: 10983377
[TBL] [Abstract][Full Text] [Related]
2. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
[TBL] [Abstract][Full Text] [Related]
3. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
4. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
5. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
[TBL] [Abstract][Full Text] [Related]
7. [P53 protein and human papillomavirus oncogenes in carcinogenesis of the uterine cervix].
Toledo-Cuevas EM; García-Carrancá A
Rev Invest Clin; 1996; 48(1):59-68. PubMed ID: 8815489
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
9. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L
Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor. Expression in human vulvar neoplastic and nonneoplastic tissues.
Doldi N; Origoni M; Bassan M; Ferrari D; Rossi M; Ferrari A
J Reprod Med; 1996 Nov; 41(11):844-8. PubMed ID: 8951136
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
[TBL] [Abstract][Full Text] [Related]
12. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
Alazawi W; Pett M; Arch B; Scott L; Freeman T; Stanley MA; Coleman N
Cancer Res; 2002 Dec; 62(23):6959-65. PubMed ID: 12460913
[TBL] [Abstract][Full Text] [Related]
13. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
[TBL] [Abstract][Full Text] [Related]
14. The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism.
Clere N; Bermont L; Fauconnet S; Lascombe I; Saunier M; Vettoretti L; Plissonnier ML; Mougin C
Exp Cell Res; 2007 Sep; 313(15):3239-50. PubMed ID: 17678892
[TBL] [Abstract][Full Text] [Related]
15. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
16. Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors.
Pillai MR; Nair MK
Exp Mol Pathol; 2000 Dec; 69(3):233-41. PubMed ID: 11115364
[TBL] [Abstract][Full Text] [Related]
17. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
[TBL] [Abstract][Full Text] [Related]
18. Prevention of carcinoma of cervix with human papillomavirus vaccine.
Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
[TBL] [Abstract][Full Text] [Related]
19. Physical status of HPV types 16 and 18 in topographically different areas of genital tumours and in paired tumour-free mucosa.
Badaracco G; Venuti A
Int J Oncol; 2005 Jul; 27(1):161-7. PubMed ID: 15942656
[TBL] [Abstract][Full Text] [Related]
20. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
